You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for Novo Nordisk Inc. v. Alvogen, Inc. (D. Del. 2022)

✉ Email this page to a colleague

« Back to Dashboard

Novo Nordisk Inc. v. Alvogen, Inc. (D. Del. 2022)

Docket	⤷ Sign Up	Date Filed	2022-03-04
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Patents	10,220,155; 10,335,462; 8,129,343; 8,920,383; 9,132,239; 9,457,154; 9,687,611; 9,775,953; RE46,363
Link to Docket	External link to docket

Small Molecule Drugs cited in Novo Nordisk Inc. v. Alvogen, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Biologic Drugs cited in Novo Nordisk Inc. v. Alvogen, Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Novo Nordisk Inc. v. Alvogen, Inc. (D. Del. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-03-03	1	Complaint	’953 patent”), 10,220,155 (the “’155 patent”), 10,335,462 (the “’462 patent”), 11,097,063 (the “’063 … COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 10,220,155 62. Novo Nordisk re-alleges … United States Patent Nos. 8,129,343 (the “’343 patent”), 8,920,383 (the “’383 patent”), 9,132,239 (the…(the “’239 patent”), 9,457,154 (the “’154 patent”), 9,687,611 (the “’611 patent”), 9,775,953 (the “’953… 1. This is an action for patent infringement under the patent laws of the United States, Title	External link to document
2022-03-03	4	Patent/Trademark Report to Commissioner of Patents	;9,132,239 B2 ;9,457,154 B2 ;9,687,611 B2 ;10,335,462 B2. (mal) (Entered: 03/04/2022) 4 March 2022… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,129,343 B2 ;… 4 March 2022 1:22-cv-00299 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.